Sign Up to like & get
recommendations!
0
Published in 2020 at "Veterinary and comparative oncology"
DOI: 10.1111/vco.12590
Abstract: We previously reported that eBAT, an EGF-targeted angiotoxin, was safe and improved overall survival for dogs with splenic hemangiosarcoma when added to the standard of care in a single cycle of three administrations in the…
read more here.
Keywords:
chemotherapy;
angiotoxin;
splenic hemangiosarcoma;
dogs splenic ... See more keywords